Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 19, 2007 - Issue 5
117
Views
27
CrossRef citations to date
0
Altmetric
Original Articles

Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users

, , , , &
Pages 637-645 | Published online: 25 Jun 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Soroush Moallef, Ekaterina Nosova, Seonaid Nolan, Nadia Fairbairn, Jane Loh, Kanna Hayashi & M.-J. Milloy. (2021) Prevalence and longitudinal correlates of recent exposure to fentanyl among HIV-positive people who use unregulated drugs during a community-wide overdose crisis. AIDS Care 33:12, pages 1560-1568.
Read now
Santosh Kumar, PSS Rao, Ravindra Earla & Anil Kumar. (2015) Drug–drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems. Expert Opinion on Drug Metabolism & Toxicology 11:3, pages 343-355.
Read now
Santosh Kumar, Mengyao Jin, Anusha Ande, Namita Sinha, Peter S Silverstein & Anil Kumar. (2012) Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes. Expert Opinion on Drug Metabolism & Toxicology 8:11, pages 1363-1375.
Read now

Articles from other publishers (24)

Jing Sun, Shruti H. Mehta, Jacquie Astemborski, Damani A. Piggott, Becky L. Genberg, Tanita Woodson‐Adu, Eve‐Marie Benson, David L. Thomas, David D. Celentano, David Vlahov & Gregory D. Kirk. (2021) Mortality among people who inject drugs: a prospective cohort followed over three decades in Baltimore, MD, USA. Addiction 117:3, pages 646-655.
Crossref
Bianca Cotto, Kalimuthusamy Natarajanseenivasan & Dianne Langford. (2019) HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders. Progress in Neurobiology 181, pages 101616.
Crossref
Anthony T. Fojo, Catherine R. Lesko, Keri L. Calkins, Richard D. Moore, Mary E. McCaul, Heidi E. Hutton, William C. Mathews, Heidi Crane, Katerina Christopoulos, Karen Cropsey, Michael J. Mugavero, Kenneth Mayer, Brian W. Pence, Bryan Lau & Geetanjali Chander. (2018) Do Symptoms of Depression Interact with Substance Use to Affect HIV Continuum of Care Outcomes?. AIDS and Behavior 23:3, pages 580-591.
Crossref
Priya Bhagwat, Shashi N Kapadia, Heather J Ribaudo, Roy M Gulick & Judith S Currier. (2019) Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy. Open Forum Infectious Diseases 6:2.
Crossref
Monique J Brown, Julianne M Serovich, Tanja C Laschober & Judy A Kimberly. (2018) Age and racial disparities in substance use and self-reported viral suppression among men who have sex with men with HIV. International Journal of STD & AIDS 29:12, pages 1174-1182.
Crossref
Mary Clare Kennedy, Thomas H. Kerr, Evan Wood, Jeannie A. Shoveller, Julio S.G. Montaner & M-J S. Milloy. (2018) Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users. AIDS 32:8, pages 1059-1067.
Crossref
Mimi Tran, Evan Wood, Thomas Kerr, Sophie Patterson, David Bangsberg, Huiru Dong, Silvia Guillemi, Julio SG Montaner & M-J Milloy. (2016) Increases in CD4 + T-Cell Count at Antiretroviral Therapy Initiation among HIV-Positive Illicit Drug users during a Treatment-as-Prevention Initiative in Canada . Antiviral Therapy 22:5, pages 403-411.
Crossref
Julia Dickson-Gomez, Gloria Bodnar, Andy Petroll, Kali Johnson & Laura Glasman. (2015) HIV Treatment for Alcohol and Non-Injection Drug Users in El Salvador. Qualitative Health Research 25:12, pages 1719-1732.
Crossref
Ryan P. Westergaard, Timothy Hess, Jacquie Astemborski, Shruti H. Mehta & Gregory D. Kirk. (2013) Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS 27:16, pages 2559-2566.
Crossref
C. G. Tsiara, G. K. Nikolopoulos, N. L. Dimou, P. G. Bagos, G. Saroglou, E. Velonakis & A. Hatzakis. (2013) Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis. Journal of Viral Hepatitis 20:10, pages 715-724.
Crossref
Ryan P. Westergaard, Anne C. Spaulding & Timothy P. Flanigan. (2013) HIV among persons incarcerated in the USA. Current Opinion in Infectious Diseases 26:1, pages 10-16.
Crossref
Tsung-chieh Fu, Ryan P. Westergaard, Bryan Lau, David D. Celentano, David Vlahov, Shruti H. Mehta & Gregory D. Kirk. (2012) Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users. AIDS 26:18, pages 2383-2391.
Crossref
C. W. Claassen, M. Diener-West, S. H. Mehta, D. L. Thomas & G. D. Kirk. (2012) Discordance Between CD4+ T-Lymphocyte Counts and Percentages in HIV-Infected Persons With Liver Fibrosis. Clinical Infectious Diseases 54:12, pages 1806-1813.
Crossref
Michael-John S. Milloy, Brandon D.L. Marshall, Thomas Kerr, Jane Buxton, Tim Rhodes, Julio Montaner & Evan Wood. (2012) Social and structural factors associated with HIV disease progression among illicit drug users. AIDS 26:9, pages 1049-1063.
Crossref
M Murray, RS Hogg, VD Lima, MT May, DM Moore, S Abgrall, M Bruyand, A D'Arminio Monforte, C Tural, MJ Gill, RJ Harris, P Reiss, A Justice, O Kirk, M Saag, CJ Smith, R Weber, J Rockstroh, P Khaykin & JAC Sterne. (2011) The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Medicine 13:2, pages 89-97.
Crossref
Ryan P Westergaard, Bridget K Ambrose, Shruti H Mehta & Gregory D Kirk. (2012) Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers. Journal of the International AIDS Society 15:1, pages 10.
Crossref
Janaina AS Casotti, Luciana N Passos, Fabiano JP Oliveira & Crispim CeruttiJrJr. (2011) Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study. BMC Infectious Diseases 11:1.
Crossref
Adam Gonzalez, Jennifer Barinas & Conall O’Cleirigh. (2011) Substance Use: Impact on Adherence and HIV Medical Treatment. Current HIV/AIDS Reports 8:4, pages 223-234.
Crossref
R. P. Westergaard, G. D. Kirk, D. R. Richesson, N. Galai & S. H. Mehta. (2011) Incarceration Predicts Virologic Failure for HIV-Infected Injection Drug Users Receiving Antiretroviral Therapy. Clinical Infectious Diseases 53:7, pages 725-731.
Crossref
M-J MilloyEvan Wood. (2010) HIV treatment in the criminal justice system. HIV Therapy 4:5, pages 519-522.
Crossref
David M Moore, Ross Harris, Viviane Lima, Bob Hogg, Margaret May, Benita Yip, Amy Justice, Amanda Mocroft, Peter Reiss, Fiona Lampe, Geneviève Chêne, Dominique Costagliola, Luigia Elzi, Michael J Mugavero, Antonella D'Arminio Monforte, Caroline Sabin, Daniel Podzamczer, Gerd Fätkenheuer, Schlomo Staszewski, John Gill & Jonathan A C Sterne. (2009) Effect of Baseline CD4 Cell Counts on the Clinical Significance of Short-Term Immunologic Response to Antiretroviral Therapy in Individuals With Virologic Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes 52:3, pages 357-363.
Crossref
Julio CollazosVíctor AsensiJosé Antonio Cartón. (2009) CD4 Responses in the Setting or Suboptimal Virological Responses to Antiretroviral Therapy: Features, Outcomes, and Associated Factors. AIDS Research and Human Retroviruses 25:7, pages 647-655.
Crossref
Ravi Kavasery, Noya Galai, Jacquie Astemborski, Gregory M Lucas, David D Celentano, Gregory D Kirk & Shruti H Mehta. (2009) Nonstructured Treatment Interruptions Among Injection Drug Users in Baltimore, MD. JAIDS Journal of Acquired Immune Deficiency Syndromes 50:4, pages 360-366.
Crossref
Ruimin Tan, Andrew O Westfall, James H Willig, Michael J Mugavero, Michael S Saag, Richard A Kaslow & Mirjam C Kempf. (2008) Clinical Outcome of HIV-Infected Antiretroviral-Naive Patients With Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 47:5, pages 553-558.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.